| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |